As AIM brokers and advisers we are dedicated to fund raising, share price support and providing market-driven corporate finance advice.
We raise capital for companies in the most efficient manner possible whether by straight equity or otherwise.
We communicate the investment cases of our clients to the market through equity research, investor road shows and private investor newsletters.
We provide market-driven corporate finance advice to our clients to help deliver shareholder value.
Because our service is highly personal, every client and every deal is important to us.
Growth Company Convertible Bond (GCCB)
The Growth Company Convertible Bond (GCCB) provides growth companies with the opportunity to raise significant sums to fund acquisitions or other strategic investments.
A convertible bond is a bond issued by a company (the issuer) which can be converted at the investor's option at any time through the life of the bond into a fixed number of ordinary shares of the issuer.
The principle advantages to the issuer are:
Equity at a premium - the bonds are convertible at a premium (typically 25%-30%) to the current share price so the issuer benefits by raising equity on non-dilutive terms - and sends a signal as to expected share price growth.
Diversification of shareholder base - the bonds will approach a different investor base from straight equity or debt and will help extend and diversify the investor base for the issuer.
Attractive debt funding - if the bonds are not converted they provide debt funding at an attractive rate, below that obtainable from bank lenders, in what will be a rising interest environment.
Flexibility the terms of the GCCB will be tailored to the issuer's financing requirements including maturity, premium, call features, etc.
The GCCB focuses on the potential of growth companies and it is a collaboration between Hybridan and a full service investment bank headquartered in London.
The Amortising Bond (AB)
Equity linked funding with a difference - the Amortising Bond (AB).
The Amortising Bond (AB) provides growth companies with the opportunity to raise significant sums to fund acquisitions or other strategic investments on attractive terms.
The AB is a corporate bond issued by a company (the issuer) that is repayable through regular monthly payments (at the choice of the issuer) in either shares or cash. If payments are made in shares the number of shares to be issued is determined by the issuer's share price at the time of the payment.
The principle advantages to the issuer are:
Cash is available as a lump sum without restriction on completion - exactly like a straight bond issue and in contrast to the traditional equity financing structres.
The issuer benefits from share price growth - any payment is made by reference to the prevailing share price of the issuer at the time of payment.
Attractive debt funding - an attractive rate (typically 8 per cent, per annum) below that obtainable from bank lenders.
Flexibility - the terms of the AB will be tailored to the issuer's financing requirements (including amount, repayment terms, early repayment etc) and does not include financial covenants.
The AB is an unlisted corporate bond available to companies that benefit from a good degree of liquidity in their shares. The bond is generally placed with a single investor based outside the UK.
We help deliver shareholder value through corporate finance advice covering:
Public company takeover and Take-over code advice including Rule 3 roles, Rule 9 waivers and "public to privates" transactions.
UK Listing Rules, AIM Rules and PLUS Markets Rules (as PLUS corporate adviser) advice including reversal transactions, transferring between markets and delistings.
Strategic advice on corporate transactions including acquisitions and disposals and capital restructurings (including share buy-backs).
Pre-IPO, IPO and secondary fundraising.
Equity Placings:
The most common and quickest form of raising capital for quoted companies. Our marketing roadshows are focussed, time efficient and successful.
Structured Finance:
We have a rare ability to structure capital raisings, for example by structured equity or convertible bonds, which address a range of issues including dilution and valuation.
Private Equity:
Our deep relationships with private equity investors, VCs and family offices allows us to give a rapid view on their likely level of interest in a transaction.
Management Buy-outs and Take Privates:
Many investors continue to see attractive opportunities to fund take private transactions.
Recent Transactions:
See our list of recent transactions by CLICKING HERE.
We use our class leading research to persistently sell our clients to the full universe of professional small cap investors:
* Small Cap Fund Managers and Hedge Funds
* Private Client Brokers
* Family Offices and Ultra High Net Worths
Our innovative weekly newsletter, the Hybridan Small Cap Wrap, communicates small cap news to retail investors.
Our Sales & Trading Department actively seeks out buyers and sellers, often for illiquid or otherwise hard to place lines of stock.
Research
The hallmark of our research is a level of analysis uncommon in small caps.
Our research product is distributed across the City and widely respected by investors who actually invest in small cap companies.
Our thorough and insightful analysis will always provide a clear investment case and usually valuation guidance.
Our client's priorities are our priorities: Our own long-term success will follow from the diligent approach we take to meeting a client's requirements.
We offer a fresh perspective: We constantly strive to deliver innovative financial solutions to our clients, often by taking an "outside the box" approach.
Execution - we do what we say: We deliver what we promise, without wavering, and with great pride.
A team that works: the sum of the parts is far greater than the sum of the individual parts. In the increasingly complex world of finance, we appreciate diversity in knowledge and skill, and have brought together a team that successfully reflects this.
